Isabelle Mahé

19PUBLICATIONS
71CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Respiratory diseasesHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 13, 2026
Prognosis of Recurrent Venous Thromboembolism During Extended Apixaban Therapy for Cancer-Associated Thrombosis: Insights From the API-CAT Randomized Trial.

|Jun 26, 2026
API-CAT Investigators' Decisions on Anticoagulation following Extended Treatment for Cancer VTE.

|Feb 18, 2026
Complications in patients with cancer-associated thrombosis on tinzaparin by cancer site and frailty: a pooled analysis.

Isabelle Mahe, Celine Chapelle, Philippe Girard

|Nov 25, 2025
Tinzaparin Pharmacokinetics in Patients with Cancer: A Comparative Modeling Study.

Xavier Delavenne, Jean Escal, Dominique Helley

|Sep 01, 2025
Anti-thrombotic therapy in patients with cancer at the end of life: A cohort study using population-linked routinely collected data.

Sarah J Aldridge, Ashley Akbari, Adrian Edwards

|Mar 31, 2025
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.

Isabelle Mahé, Marc Carrier, Didier Mayeur

Pageof 4

Frequent Collaborators

5 joint publications

Laurent Bertoletti

5 joint publications

Frederikus A Klok

3 joint publications

Silvy Laporte

3 joint publications

Juan José López-Núñez